Kevin R. Lind
2021 - Longboard Pharmaceuticals
In 2021, Kevin R. Lind earned a total compensation of $875.1K as President and Chief Executive Officer at Longboard Pharmaceuticals, a 62% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $316,726 |
---|---|
Salary | $546,616 |
Other | $11,792 |
Total | $875,134 |
Lind received $546.6K in salary, accounting for 62% of the total pay in 2021.
Lind also received $316.7K in non-equity incentive plan and $11.8K in other compensation.
Rankings
In 2021, Kevin R. Lind's compensation ranked 9,206th out of 12,415 executives tracked by ExecPay. In other words, Lind earned more than 25.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,206 | 26th |
Manufacturing | 4,086 | 26th |
Chemicals And Allied Products | 1,802 | 24th |
Drugs | 1,602 | 24th |
Pharmaceutical Preparations | 1,189 | 23rd |
Lind's colleagues
We found two more compensation records of executives who worked with Kevin R. Lind at Longboard Pharmaceuticals in 2021.